flurbiprofen has been researched along with Scleritis in 4 studies
Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.
Scleritis: Refers to any inflammation of the sclera including episcleritis, a benign condition affecting only the episclera, which is generally short-lived and easily treated. Classic scleritis, on the other hand, affects deeper tissue and is characterized by higher rates of visual acuity loss and even mortality, particularly in necrotizing form. Its characteristic symptom is severe and general head pain. Scleritis has also been associated with systemic collagen disease. Etiology is unknown but is thought to involve a local immune response. Treatment is difficult and includes administration of anti-inflammatory and immunosuppressive agents such as corticosteroids. Inflammation of the sclera may also be secondary to inflammation of adjacent tissues, such as the conjunctiva.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Retrospective chart review of 126 patients with non-necrotizing anterior scleritis treated with oral flurbiprofen (Froben®(Abbott Healthcare)) with (Group B, n = 61) or without (Group A, n = 65) topical steroids was performed and time to remission was plotted." | 7.83 | Flurbiprofen: A Nonselective Cyclooxygenase (COX) Inhibitor for Treatment of Noninfectious, Non-necrotizing Anterior Scleritis. ( Agrawal, R; Gonzalez-Lopez, JJ; Khan, S; Lee, CS; Pavesio, C; Rodrigues, V, 2016) |
| "Retrospective chart review of 126 patients with non-necrotizing anterior scleritis treated with oral flurbiprofen (Froben®(Abbott Healthcare)) with (Group B, n = 61) or without (Group A, n = 65) topical steroids was performed and time to remission was plotted." | 3.83 | Flurbiprofen: A Nonselective Cyclooxygenase (COX) Inhibitor for Treatment of Noninfectious, Non-necrotizing Anterior Scleritis. ( Agrawal, R; Gonzalez-Lopez, JJ; Khan, S; Lee, CS; Pavesio, C; Rodrigues, V, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agrawal, R | 1 |
| Lee, CS | 1 |
| Gonzalez-Lopez, JJ | 1 |
| Khan, S | 1 |
| Rodrigues, V | 1 |
| Pavesio, C | 2 |
| Cunningham, ET | 1 |
| McCluskey, P | 1 |
| Wakefield, D | 1 |
| Zierhut, M | 1 |
| Nessim, M | 1 |
| Kyprianou, I | 1 |
| Kumar, V | 1 |
| Murray, PI | 1 |
| Lyons, CJ | 1 |
| Hakin, KN | 1 |
| Watson, PG | 1 |
1 trial available for flurbiprofen and Scleritis
| Article | Year |
|---|---|
Topical flurbiprofen: an effective treatment for episcleritis?
Topics: Administration, Topical; Adult; Aged; Double-Blind Method; Female; Flurbiprofen; Humans; Male; Middl | 1990 |
3 other studies available for flurbiprofen and Scleritis
| Article | Year |
|---|---|
Flurbiprofen: A Nonselective Cyclooxygenase (COX) Inhibitor for Treatment of Noninfectious, Non-necrotizing Anterior Scleritis.
Topics: Administration, Oral; Adult; Aged; Anterior Eye Segment; Cohort Studies; Cyclooxygenase Inhibitors; | 2016 |
Scleritis.
Topics: Cyclooxygenase Inhibitors; Female; Flurbiprofen; Humans; Male; Middle Aged; Scleritis | 2016 |
Anterior scleritis, scleral thinning, and intraocular pressure measurement.
Topics: Anti-Inflammatory Agents; Disease Progression; Drug Therapy, Combination; Female; Flurbiprofen; Huma | 2005 |